Cartesian Therapeutics, Inc. · NASDAQ:RNAC
FMR LLC reported a 5.30% stake in Cartesian Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 5, 2026
FMR LLC reported a 5.30% stake in Cartesian Therapeutics, Inc., 1,366,989 shares, as a passive investor on Dec 31, 2025. Filed Feb 5, 2026 (Schedule 13G/A).
- Stake
- 5.30%
- Shares
- 1,366,989
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 5.30% | 1,366,989 |
| Abigail P. Johnson | 5.30% | 1,366,989 |
Source
Related
- Cartesian Therapeutics, Inc.
- FMR LLC
- Cartesian Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · FMR LLC · Nov 5, 2025
- Schedule 13G/A · FMR LLC · Feb 12, 2025
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Jul 22, 2026
- Form 4 · Hoge Elizabeth · Apr 6, 2026
- Form 4 · Kalayoglu Murat · Apr 6, 2026
- Schedule 13G · Squarepoint Ops LLC · Mar 13, 2026